SFI
IMNN icon

Susquehanna Fundamental Investments’s Imunon IMNN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-125
Closed -$18K – 1544
2020
Q3 		$18K Buy
125
+67
+116% +$16.9K ﹤0.01% 1347
2020
Q2 		$42K Buy
+58
New +$25.1K ﹤0.01% 946

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
EP
Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna Fundamental Investments's IMNN Position: Q4 2020 in Review

Susquehanna Fundamental Investments sold out of Imunon (IMNN) in Q4 2020, closing a stake of 125 shares — an estimated $18K sold.

Susquehanna Fundamental Investments first reported a position in IMNN in Q2 2020 and held it in 2 quarters. The position peaked at $42K in Q2 2020. 25 funds tracked by Wall St. Rank hold IMNN as of Q4 2020.

  • Susquehanna Fundamental Investments reported no remaining Imunon position as of Q4 2020 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 125 Imunon shares in Q4 2020, an estimated $18K.
  • Susquehanna Fundamental Investments first reported a position in Imunon in Q2 2020 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's Imunon position peaked at $42K in Q2 2020.
  • 25 funds tracked by Wall St. Rank held Imunon as of Q4 2020.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2020, filed 16 Feb 2021.